Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings

Shares (Q2 2026)
6,421
Value
$478.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BBIO by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,421$478.2K<0.1%−25,256−79.7%ReducedHolders
Q1 202631,677$2.35M<0.1%−5,843−15.6%ReducedHolders
Q4 202537,520$2.87M<0.1%+3,970+11.8%AddedHolders
Q3 202533,550$1.74M<0.1%−5,606−14.3%ReducedHolders
Q2 202539,156$1.69M<0.1%+136+0.3%AddedHolders
Q1 202539,020$1.35M<0.1%−9,519−19.6%ReducedHolders
Q4 202448,539$1.33M<0.1%+10,864+28.8%AddedHolders
Q3 202437,675$959.2K<0.1%+10,498+38.6%AddedHolders
Q2 202427,177$688.4K<0.1%−6,104−18.3%ReducedHolders
Q1 202433,281$1.03M<0.1%+3,209+10.7%AddedHolders
Q4 202330,072$1.21M<0.1%+4,569+17.9%AddedHolders
Q3 202325,503$672.5K<0.1%+223+0.9%AddedHolders
Q2 202325,280$434.8K<0.1%+2,324+10.1%AddedHolders
Q1 202322,956$380.6K<0.1%−3,030−11.7%ReducedHolders
Q4 202225,986$198.0K<0.1%+1,985+8.3%AddedHolders
Q3 202224,001$239.0K<0.1%−1,019−4.1%ReducedHolders
Q2 202225,020$227.0K<0.1%−12,617−33.5%ReducedHolders
Q1 202237,637$381.0K<0.1%−8,968−19.2%ReducedHolders
Q4 202146,605$778.0K<0.1%−1,766−3.7%ReducedHolders
Q3 202148,371$2.27M<0.1%−6,373−11.6%ReducedHolders
Q2 202154,744$3.34M<0.1%+8,822+19.2%AddedHolders
Q1 202145,922$2.83M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.